Atovaquone/proguanil for plasmodium falciparum malaria.
Sehdev
Paul S
PS
University of maryland School of Medicine, Baltimore, MD, USA.
D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D053626:Atovaquone; D018849:Controlled Clinical Trials as Topic; D004338:Drug Combinations; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000469:parasitology; D009285:Naphthoquinones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010963:Plasmodium falciparum / Q000187:drug effects; D002727:Proguanil / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000962:Antimalarials; D004338:Drug Combinations; D009285:Naphthoquinones; D002727:Proguanil; D053626:Atovaquone